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The effect of dietary vitamin E on immunoglobulin A (IgA) antibody production, which acts as
the first line of defence at the intestinal mucosa, has not been evaluated in chickens. In the pre-
sent study the impact of the inclusion of supplementary levels of vitamin E to the diet, on total
and antigen-specific IgA antibody titres, T-cell subsets and Ia cells, was assessed. From hatch-
ing, chickens received a maize-based diet which was supplemented with either 25, 250, 2500 or
5000 mg dl-a-tocopherol acetate/kg. Primary immunisation with tetanus toxoid (T. toxoid)
emulsified in a vegetable oil-in-water adjuvant was administered by the intraperitoneal route
at 21 d of age. At 35 d of age all birds received an oral booster vaccination of T. toxoid. Sig-
nificantly higher total IgA antibody titres were present in the day 42 intestinal scrapings of birds
receiving the 5000 mg/kg vitamin E-supplemented diet (VESD) (P0·05) and a notable
increase was observed in birds receiving the 250 mg/kg VESD (P0·06). At days 21 and 42
total serum IgA antibody titres of birds receiving the 250 mg/kg VESD was significantly
higher (P,0·05) than the control birds. Following immunisation with T. toxoid, birds receiving
the 250 and the 5000 mg/kg VESD had elevated anti-T. toxoid IgA antibody titres in final day
intestinal scrapings, which, for the latter group was statistically significant (P0·02). Both of
these groups also demonstrated increased titres of anti-T. toxoid IgA in the serum at day 42.
Birds receiving the 250 mg/kg VESD exhibited a notable increase in the percentage of
T-helper cells and Ia cells in peripheral blood on day 26. The results illustrate the potential
for some levels of dietary vitamin E supplementation to act as an immunomodulator of total and
antigen-specific IgA antibody.
Vitamin E: Immunoglobulin A: Avian intestinal immunity: Chickens
The addition of vitamin E to diets at concentrations higher
than the requirements for nutritional and reproductive
needs (Bendich et al. 1986; Tengerdy, 1990) will modulate
many facets of the immune system. This includes cell-
mediated and humoral immune responses, macrophage
function and phagocytosis and improved resistance to dis-
ease (Finch & Turner, 1996). Vitamin E influences the
development of the immune system in chickens, as a
deficiency reduces growth of lymphoid organs (Marsh
et al. 1986) and the number of circulating lymphocytes
(Dietert et al. 1983). In contrast, chicks on vitamin E sup-
plemented-diets have an increase in the percentage of
CD4 thymocytes and splenocytes (Erf et al. 1998),
increased lymphocyte proliferation (Haq et al. 1996), and
an increase in heterophils:lymphocytes (Boa-Amponsem
et al. 2000). Supplementary dietary vitamin E generally
improved antibody production (Franchini et al. 1986;
Haq et al. 1996; Gore & Qureshi, 1997; Friedman et al.
1998; Boa-Amponsem et al. 2000), macrophage activity
and phagocytic potential (Tengerdy & Brown, 1977;
Gore & Qureshi, 1997; Qureshi & Gore, 1997). Further-
more, vitamin E supplementation of poultry diets has
improved resistance to disease challenges with Eimeria
tenella (Colnago et al. 1984) and Escherichia coli (Hein-
zerling et al. 1974; Tengerdy & Brown, 1977).
Studies in chickens of Newcastle disease virus (Haq et al.
1996; Friedman et al. 1998), E. coli (Heinzerling et al.
1974; Tengerdy & Brown, 1977; Friedman et al. 1998)
and Eimeria tenella (Colnago et al. 1984) have shown
that supplementation of the diet with vitamin E improves
antibody (agglutination and immunoglobulin (Ig) G iso-
type) responses to pathogens which interact at mucosal
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surfaces. Local mucosal production of IgA antibody plays
an important role in protecting mucosal surfaces from
pathogens (Muir et al. 2000a), but the influence of vitamin
E on total or antigen-specific IgA antibody levels has not
been evaluated in chickens. However, the potential for
vitamin E supplementation to increase IgA antibody pro-
duction has been demonstrated in rodents fed diets contain-
ing between 0·1 % (Kaku et al. 1999) and 0·2 % (Gu et al.
1999) tocopherol. More specifically increased IgA pro-
ductivity of lymphocytes in the mesenteric lymph nodes
(Gu et al. 1999; Kaku et al. 1999), and elevated IgA anti-
body levels in serum (Kaku et al. 1999) and at the intesti-
nal surface (Watson & Messiha, 1987) have been observed.
The induction of an antigen-specific antibody-based
immune response requires the antigen to be expressed by
antigen-presenting cells in association with class II major
histocompatibility molecules (MHC-II). The Ia antigen is
an MHC-II product, and its expression provides an indi-
cation of the level of antigen presentation via MHC-II.
Downstream from antigen-presentation IgA antibody pro-
duction is closely regulated by T-cells, in particular
T-helper (Th) cells (Kiyono & McGhee, 1994), and, an
increase in the Th cell population favours increased anti-
body production. A number of studies investigating the
impact of vitamin E on immune responses have observed
alterations in Ia and T cell subset populations (Chang
et al. 1994; Erf et al. 1998). In the present study the per-
centage of Th cells (CD4), T suppressor cells (CD8)
and Ia cells in peripheral blood (PB) were determined
before and after vaccination of the chickens.
The present study was designed to determine if dietary
supplementation with vitamin E at levels above those
required to meet nutritional requirements (National
Research Council, 1994), and, including levels shown to
increase IgA production in rodents (Gu et al. 1999),
would upregulate IgA antibody production in chickens.
Chicks received vitamin E-supplemented diet (VESD) for
the duration of the study, and IgA antibody titres were
determined before and after vaccination with an immunis-
ation protocol which stimulates significant IgA antibody at
the intestinal surface (Muir et al. 1995). In particular the
titre of total and anti-antigen IgA antibody at the intestinal
mucosa and the percentage of CD4, CD8 and Ia cells
was determined.
Materials and methods
Chickens and diets
One-d-old male broiler chickens (Cobb) were obtained
from Inghams hatchery (Casula, Australia). Before dis-
patch the chicks were vaccinated with Marek’s disease
virus and infectious bronchitis virus. Chicks were housed
in wire-floor brooders until 18 d old, and then transferred
to carry-on cages in a continuously illuminated room main-
tained at 228C. Feed and water were available ad libitum.
At 1 d old all chicks were randomly allocated to twenty-
five pens, each containing six chicks. Five pens were ran-
domly allocated to each dietary treatment, which the chicks
received for the duration of the study. All treatment groups
received a maize-based basal diet (Table 1) containing
120 mg tocopherol acetate/kg determined by HPLC anal-
ysis (Lumley, 1993). Of this, 50 mg vitamin E/kg was
derived from the commercial broiler premix (BASF,
Homebush, NSW, Australia). To prepare the VESD, the
basal diet was supplemented with 0, 25, 250, 2500 and
5000 mg dl-a-tocopherol acetate/kg in Lutavit E 50 S
(BASF), which consisted of 50 % dl-a-tocopherol acetate
in a milk powder–gelatin matrix. Between days 21 and
42 feed intake was determined for each treatment group,
and individual bird weights were recorded on days 21
and 42. Feed conversion ratio was calculated for this
period.
Ethical considerations
All experimental procedures were approved by the Univer-
sity of Sydney Animal Ethics Committee, and complied
with the Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes.
Antigen and vaccinations
A crude preparation of tetanus toxoid (T. toxoid), prepared
by formalin treatment of Clostridium tetani culture super-
natant fractions was obtained from Commonwealth
Serum Laboratories, Melbourne, Australia. This was
adjusted to 1500 limit flocculation units/ml by the addition
of sterile PBS (pH 7·3).
At 21 d of age all chickens received a primary, intraperi-
toneal immunisation with T. toxoid emulsified in a vegetable
oil-based adjuvant (Husband, 1993), with Quil A (Superfos,
Denmark; 1 mg/dose). At 35 d of age all chickens received an
oral booster immunisation.
Sample collections
Blood samples were collected from the jugular vein of each
Table 1. Composition of the basal experimental diet
Ingredients g/kg
Maize 566·8
Soyabean meal 360·0
Vegetable oil 30·0
Limestone 16·6
Dicalcium phosphate 14·3
Vitamin–mineral premix (broiler)* 5·0
Sodium chloride 3·0
DL-methionine 2·3
Choline chloride 2·0
Calculated analysis
Metabolisable energy (MJ/kg) 12·9
Crude protein 210·0
Lysine 11·8
Methionine–cystine 9·0
Ca 10·1
Total P 6·9
* Vitamin–mineral premix (BASF, Homebush, NSW, Australia) provided (/kg
diet) vitamin A, 3·6 mg, vitamin D3, 60mg, thiamine, 0·8 g; vitamin B12,
6 mg; folic acid, 0·6 g; Co, 0·04 g; I, 0·2 g; Mo, 0·04 g; riboflavin, 5 g; pyri-
doxine, 2·4 g; vitamin E, 10 g; menadione, 0·8 g; pantothenic acid, 6 g; nia-
cin, 24 g; biotin, 0·06 g; Mn, 40 g; Zn, 32 g; Mg, 40 g; Fe, 32 g; Cu, 4 g; Se,
0·04 g; endox, 50 g; liquid paraffin white, 10 g.
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chicken on days 21 and 42. Serum was prepared and stored
at 2208C until assayed. On days 19, 26, 33 and 40 samples
of PB were collected from six chickens in each treatment
group for determination of CD4 and CD8 T cell subsets
and Ia cells, using flow cytometry.
At the end of the experiment all chickens were eutha-
nased by intravenous administration of sodium pentobarbi-
tone. Samples of intestinal scrapings were obtained from
the length of jejunum after the serosal and mucosal sur-
faces were washed in ice cold PBS. The samples were
immediately frozen on dry ice and stored at 2808C. The
intestinal scrapings supernatant fraction (ISS) was col-
lected for antibody determination following ultracentrifu-
gation at 24000 g for 60 min (Duncan et al. 1978).
Antibody detection by ELISA
An indirect ELISA was used to determine T. toxoid-
specific IgA and total IgA in serum and ISS. To determine
IgA antibodies to T. toxoid polysorb ELISA plates (Nunc
Immuno, Medos Company, Sydney, Australia) were
coated with 100ml purified T. toxoid (diluted 1:100 in car-
bonate buffer), and incubated overnight at 48C. All sub-
sequent incubations were for 1 h at 378C. Between each
incubation, plates were washed twice in washing buffer
(0·05 % Tween 20 and 0·5 M NaCl in PBS) and PBS,
then tapped dry. Plates were blocked with 0·25 % gelatin
in washing buffer. Serum was diluted 1:25, ISS 1:20 and
the horseradish peroxidase-conjugated goat anti-chicken
IgA (Bethyl Laboratories, Montgomery, TX, USA) was
diluted 1:100 in washing buffer containing 1 % bovine
serum albumin. Neat 2·20-azino-d:[3-ethyl-benzthiazoline
sulfonate] (ABTS) substrate (Kirkegaard and Perry Labora-
tories, Gaithersburg, MD, USA) was incubated for 30 min
at room temperature and the reaction stopped with 1 %
sodium dodecyl sulfate (Kirkegaard and Perry Labora-
tories).
For total IgA analysis, maxisorb ELISA plates (Nunc
Immuno; Medos Company, Sydney, Australia) were
coated with mouse anti-chicken IgA (Southern Biotechnol-
ogy Associates, Birmingham, AL, USA) diluted 1:1000 in
carbonate buffer. Serum collected on day 21 was diluted
1:200, day 42 serum was diluted 1:400 and ISS diluted
1:500 in washing buffer. All other steps were identical to
the indirect ELISA for measuring anti-T. toxoid IgA.
Absorbance values were read at 405 nm in a Spectro Max
250 (Molecular Devices, Springvale, CA, USA) plate reader.
A negative buffer blank and a hyperimmune positive refer-
ence standard were included in each plate, and all samples
were analysed in triplicate. Sample dilutions were adjusted
to provide optical density readings on the linear portion of
the standard curve, approximately 20 % below saturation
point. Optical densities are expressed as a percentage of the
hyperimmune positive control.
Hyperimmune antiserum
Hyperimmune antisera were obtained from chickens
immunised intraperitoneally with 1500 limit flocculation
units T. toxoid/ml in a vegetable oil-in-water adjuvant
and Quil A (1 mg/dose) at days 19 and 33 of age. A
0·5 ml oral booster of 1500 limit flocculation units T.
toxoid/ml was delivered by gavage at 47 d of age. Blood
was collected 7 d later, and serum prepared and stored at
2208C.
Preparation of lymphocytes for flow cytometric analysis
Blood taken from the jugular vein was collected into hepar-
inised tubes. A total leucocyte count was determined
manually by preparing a 1:200 dilution of whole blood in
Natt and Herrick’s solution (Campbell, 1995).
Heparinised blood was centrifuged at 1300 g for 20 min.
The buffy coat was diluted in an equal volume of PBS and
then layered onto 5 ml of Ficoll Paque (Pharmacia Biotech,
Sweden). Following centrifugation at 900 g for 15 min the
layer at the interface was removed and washed twice in
PBS–5 % fetal calf serum by centrifugation at 300 g for
5 min, before enumeration and viability assessment by
trypan blue exclusion.
Flow cytometric analysis
Approximately 107 lymphocytes in 100ml PBS–fetal calf
serum were incubated with 50ml optimal dilution of
either monoclonal mouse anti-chicken CD4, CD8 or Ia
(Southern Biotechnology Associates) at 48C for 20 min.
Each sample was washed twice in 2 ml PBS, then incu-
bated with 100ml fluorescein isothiocyanate-conjugated
affinity purified goat anti-mouse immunoglobulin
(Southern Biotechnology Associates) for 20 min at 48C in
the dark, and washed as before. The cells were fixed in
0·1 % paraformaldehyde in MilliQ water (Millipore,
North Ryde, NSW, Australia), stored at 48C overnight
and analysed within 24 h of fixing. For each sample, data
were collected from 10000 events using an Ar ion laser
providing light at 488 nm. Analysis was performed on the
gated lymphoid population visually selected from the for-
ward angle and 908 light scatter properties of the dot plot
cloud. Both acquisition and analysis were undertaken on
a FACScan flow cytometer (Becton Dickinson, Sydney,
Australia) using Cell Quest software (Becton Dickinson).
For each chicken a positive control tube was analysed to
ensure minimal non-specific binding of the anti-mouse
fluorescein isothiocyanate secondary antibody.
Statistical analysis
To account for heterogeneity of variance all data were log-
transformed before analysis. A one-way ANOVA was per-
formed to determine between treatment group means.
Between group comparisons were determined using a
Tukey’s test (Sokal & Rohlf, 1995). Statistical significance
was set at P,0·05.
Results
Bird performance
Birds were clinically normal throughout the study and
between days 21 to 42 there were no significant differences
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between treatment groups in average body weight gain or
feed conversion ratio (data not shown).
Total immunoglobulin A antibody
Total IgA present at the intestinal surface, ISS, on day 42
(Fig. 1) was significantly enhanced (P0·05) in birds
receiving the 5000 mg/kg VESD and notably elevated
(P0·06) in birds receiving the 250 mg/kg VESD. Interest-
ingly, the group mean total IgA antibody titres in the ISS in
birds receiving either the 25 or the 2500 mg/kg VESD did
not differ from that of the control birds.
Mean group serum total IgA antibody titres for days 21
and 42 are presented in Fig. 1. On day 21, birds receiving
the 250 mg/kg VESD had significantly higher (P0·03)
total IgA titres than the control group. On day 42, signifi-
cantly higher total IgA antibody titres were measured in the
serum of birds receiving the 250 mg/kg VESD (P0·05)
and the 5000 mg/kg VESD (P0·003) compared with the
control group. However, birds fed the 2500 mg/kg VESD
did not show any upregulation in total IgA antibody titres.
Anti-tetanus toxoid immunoglobulin A antibody
Similar trends to those observed in total IgA antibody titres
are evident in serum and ISS anti-T. toxoid IgA antibody
titres on day 42 (Fig. 2). Group average serum anti-T.
toxoid IgA titres were highest in birds receiving the
250 mg/kg VESD, followed by birds receiving the
5000 mg/kg VESD; however, statistically there were no
significant differences between VESD treatment groups.
ISS anti-T. toxoid IgA antibody titres were significantly
elevated only in birds receiving the 5000 mg/kg VESD
(P0·02).
Peripheral blood T cell subsets and Ia cells
The percentage of CD4 and CD8 T cell subsets and
Ia cells in PB were determined on days 19, 26, 33 and
Fig. 1. Total immunoglobulin (Ig)A antibody, determined by ELISA,
in serum at day 21 (a), day 42 (b), and in intestinal scrapings super-
natant fraction (ISS) on day 42 (c) of birds receiving basal diet only
or basal diet with 25, 250, 2500 or 5000 mg supplementary vitamin
E/kg diet from day 1–42. Data are expressed as a percentage of
hyperimmune positive serum. Histograms are the mean of data
from thirty birds per group and vertical bars are standard errors.
Mean values are significantly different from that of the control
group: *P,0·05, **P,0·01.
Fig. 2. Anti-tetanus toxoid immunoglobulin (Ig)A antibody, deter-
mined by ELISA, in serum (a), and intestinal scrapings supernatant
fraction (ISS) (b) on day 42 of birds receiving basal diet only or
basal diet with 25, 250, 2500 or 5000 mg supplementary vitamin
E/kg diet from day 1–42. Data are expressed as a percentage of
hyperimmune positive serum. Histograms are the mean of data
from thirty birds per group and vertical bars are standard errors.
Mean value is significantly different from that of the control group:
*P,0·05.
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40. It was only on day 26, 5 d post primary immunisation,
that any statistically significant alterations were observed.
On day 26 all groups receiving VESD had an increase in
the group mean percentage of CD4 cells compared
with the control group. However, birds receiving the
250 mg/kg VESD had a statistically significant increase
(P0·05) in the percentage of CD4 cells (Fig. 3), and
an increase in the total number of CD4 cells (data not
shown). These birds also demonstrated a notable increase
in the percentage of Ia cells (Fig. 3) (P0·06) in PB.
Despite the alterations in antibody titres seen in birds
receiving the 5000 mg/kg VESD (Figs. 1 and 2), no signifi-
cant alterations in PB cellular subsets were observed in this
group.
Discussion
IgA-producing plasma cells located in the intestinal lamina
propria, which originate from local sites such as the bursa
of Fabricius and caecal tonsils (Muir et al. 2000b), are the
main source of IgA found at the avian intestinal surface.
The local intestinal production of IgA antibody is the
first line of defence against pathogens which gain entry
to the host through the intestinal mucosa (Muir et al.
2000a). From our previous studies it was expected that
upregulation of intestinal IgA antibody production would
improve host defence against intestinal pathogens (Muir
et al. 1998). The present study is the first report demon-
strating the ability of vitamin E to enhance mucosal IgA
antibody production in chickens. Previous avian studies
have not examined IgA production but have shown the
potential of VESD to increase total circulating antibody
(Heinzerling et al. 1974; Tengerdy & Brown, 1977; Jackson
et al. 1978; Franchini et al. 1986; Friedman et al. 1998;
Boa-Amponsem et al. 2000).
The immunisation protocol utilised is specifically
designed to stimulate a local intestinal immune response;
however, the trend in IgA antibody titre at the intestinal
site is mirrored in serum IgA antibody titres. Consistently,
the most significant increases in total IgA in the ISS and
serum were observed in birds receiving diets supplemented
with 250 and 5000 mg vitamin E/kg. Similar trends in total
IgA antibody levels were observed in anti-T. toxoid IgA
antibody titres in ISS and serum at day 42. Despite this,
no significant immunomodulatory effect was observed in
birds fed the 2500 mg VESD/kg in either total or anti-
gen-specific IgA antibody production. A non-linear dose
effect of vitamin E supplementation on avian immunoglo-
bulin production has been previously reported (Jackson
et al. 1978; Friedman et al. 1998). However, it is difficult
to compare these studies as a number of variables, includ-
ing the age and strain of the birds, the level of vitamin E
supplementation and the immunisation and/or challenge
conditions differ between experiments.
The differentiation and maturation of B cells into IgA-
producing plasma cells is closely orchestrated by Th
cells, through their cytokine profile and cell–cell contact
(Husband & Dunkley, 1990; Hodgkin et al. 1991). Altera-
tions in IgA antibody production may therefore be
accompanied by changes in the percentage of CD4 Th
cells. A number of reports have identified the potential
for dietary vitamin E supplementation to invoke CD4
Th cell activity (Tanaka et al. 1979), enhancing antibody
responses and improved disease resistance. Erf et al.
(1998) observed increased percentages of CD4CD82
thymocytes and CD4 T cells in the spleen, in 7-week-
old birds which had been maintained on a diet containing
87 mg dl-a-tocopherol acetate/kg feed. No significant
impact was observed on splenic B cells. Further, lympho-
cytes of athymic nude mice (Cook, 1991) failed to demon-
strate a ‘typical’ improved response following vitamin E
supplementation. Chickens receiving diets deficient in vita-
min E experienced a reduced proportion of T cells, particu-
larly CD4 T cells, in PB (Chang et al. 1994).
In the present study, a significant P  0·05 increase in
the percentage of CD4 cells of birds receiving the
250 mg/kg VESD, compared with the control birds, was
observed on day 26, 5 d after primary intraperitoneal
immunisation with T. toxoid. Further, on days 33 and 40
these birds demonstrated an elevation (not statistically
significantly) in the percentage of CD4 cells and, on
day 42, higher mean serum and ISS total and anti-T.
toxoid IgA compared with control birds (Figs. 1 and 2).
The alterations in PB derived CD4 cells observed
during the present experiment reflect the relationship
between PB and the focal point of the immune response
Fig. 3. CD4 (A) and CD8 (o) T cell subset (a) and Ia cells (b)
distribution determined by flow cytometry on day 26 of birds receiv-
ing basal diet only or basal diet with 25, 250, 2500 or 5000 mg sup-
plementary vitamin E/kg diet from day 1–42. Data are expressed as
a percentage of leucocytes in peripheral blood. Histograms are the
mean of data from six birds per group and vertical bars are stan-
dard errors. Mean value is significantly different from that of the
control group: *P,0·05.
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at that time, as dictated by the immunisation protocol.
Alterations in PB-derived CD4 T cells will be most evi-
dent following stimulation of the systemic immune system,
as with the day 21 primary intraperitoneal vaccination used
in the present study. A subsequent oral booster immunis-
ation will invoke a local immune response at the intestinal
site. The small increase in PB-derived CD4 cells
observed on day 40 reflects an increase in intestinal
lamina propria CD4 cells involved in the induction of
the local intestinal immune response. These outcomes con-
trast with reports from rodent studies where VESD
increased lymphocyte IgA production concurrently with a
reduction in the percentage of CD4 cells derived from
the spleen (Gu et al. 1994, 1999) and mesenteric lymph
nodes (Gu et al. 1999). However, in contrast to the present
study, the rats were not immunised.
On day 26, birds receiving the 250 mg/kg VESD also
had a notable increase (P0·06) in the mean percentage
of Ia cells in PB (Fig. 3). The Ia antigen is expressed
on B cells, mitogen-activated T cells and a subpopulation
of monocyte–macrophages (Ewert et al. 1984), which are
closely involved in the induction of a humoral immune
response. Day 26 was the only occasion when a significant
alteration in Ia cells was observed. It is interesting to note
that the birds receiving the 250 mg/kg VESD had signifi-
cantly enhanced total IgA antibody titres and elevated
anti-T. toxoid IgA antibody titres following immunisation
and also demonstrated increases in the percentage of
CD4 and Ia cells in PB at day 26. If viewed in iso-
lation, it could be concluded that these cells are the main
contributors to enhanced antibody production by vitamin
E. However, birds receiving the 5000 mg/kg VESD had
statistically significant increases in IgA antibody titres in
the absence of any significant alterations in the percentage
of these cellular subsets. As alterations in cellular subsets
can be transitory, changes in subset percentages outside
of the sampling time may have occurred.
The mechanism/s of vitamin E immunomodulation
require further elucidation. Vitamin E has been shown to
influence cell function and homeostasis, and prostaglandin
synthesis, which, through a number of interrelated pro-
cesses mediate immune function (Meydani, 1995; Meydani
& Beharka, 1996; Moriguchi & Muraga, 2000). Avian
studies also support the complex interrelationships between
vitamin E, prostaglandin production, phagocytosis and
antibody production (Tengerdy & Brown, 1977; Likoff
et al. 1981; Dietert et al. 1983; Gore & Qureshi, 1997;
Qureshi & Gore, 1997). The present study has demon-
strated the potential for some levels of dietary vitamin E
supplementation to modulate IgA antibody titres. Upregu-
lation of IgA antibody titres was observed in unimmunised
birds, as total IgA antibody, and following immunisation,
as anti-antigen IgA antibody. Increased IgA antibody was
present in the circulation and at the local intestinal site.
It would appear that a number of mechanisms are involved
in the induction of elevated antibody production, including
IgA, during dietary supplementation with vitamin E.
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